What is pathophysiology of Breast cancer?

['ነዚ ገጽ ስምዓዮ']

ፓቶፊዚዮሎጂ ናይ መንሽሮ ጡብ እንታይ እዩ?

ፓቶፊዚዮሎጂ ናይ መንሽሮ ጡብ፡ ኣብ'ቲ ልሙድ ፊዚዮሎጂካዊ መስርሕን ሜካኒዝምን፡ ኣብ ምዕባለን ምዕባለን መንሽሮ ጡብ ዘጋጥም ዘይንቡር ለውጥታት የመልክት።

እዚ ድማ ነቲ ኣብ ትሕቲኡ ዘሎ ባዮሎጂካውን ሞለክዩላውን መስርሕ መጽናዕቲ ዘጠቓልል ኮይኑ፡ እዚ ድማ ነቲ ኣብ ናይ ማህጸን ቲሹ ዘሎ ዘይቁጽጽር ዕብየትን ዝርገሐን ናይ ካንሰር ዋህዮታት ይመርሕ።

እዚ ድማ ንጀነቲካዊ፡ ኤፒጀነቲካዊን ከባቢያዊን ረቛሒታት ዘጠቃልል ኮይኑ፡ ኣብ ምጅማርን ምዕባይን ምዕባለን መንሽሮ ማህጸን ይዋሳእ።

ገለ ካብቶም ቀንዲ ናይ ማህጸን ካንሰር ፓቶፊዚዮሎጂካዊ ለውጥታት እዞም ዝስዕቡ እዮም፡

1. ጀነቲካዊ ምቅይያር:- ኣብ ገለ ጀነቲካዊ ምቅይያር ከም BRCA1 ን BRCA2 ን ናይ ማህጸን ካንሰር ናይ ምምዕባል ተኽእሎ ክብ ከብሎ ይኽእል።

እዞም ምዩቴሽን ኣብ ግዜ ህይወት ሰብ ክውረሱ ወይ ክርከቡ ይኽእሉ።

2. ሆርሞናዊ ዘይምምጥጣን፡ ሆርሞናት ብፍላይ ኤስትሮጅን፡ ኣብ ምምዕባልን ዕብየትን መንሽሮ ማህጸን ተራ ክህልዎም ይኽእል እዩ።

ናይ ሆርሞን መጠን ዘይምምጥጣን ወይ ካብ መጠን ንላዕሊ ኤስትሮጅን ምርካብ ንናይ ማህጸን ካንሰር ዘሎ ሓደጋ ከዕብዮ ይኽእል እዩ።

3. ረኽሲ:- ኣብ ናይ ማህጸን ቲሹ ዘሎ ሕዱር ረኽሲ ናይ መንሽሮ ዋህዮታት ንኽዓብዩን ንኽጸንቱን ብምትብባዕ ናይ ማህጸን መንሽሮ ንኽምዕብል ኣበርክቶ ክገብር ይኽእል ኢዩ።

4. ናይ መንሽሮ ከባቢ:- እቲ ኣብ ከባቢ መንሽሮ ዘሎ ናይ ወጻኢ ዋህዮታት: ናይ ምክልኻል ዋህዮታት: ከምኡውን ናይ ደም ዋህዮታት ነቲ ናይ ማህጸን መንሽሮ ኣብ ምዕባይን ምዝርጋሕን ጽልዋ ክህልዎ ይኽእል ኢዩ።

5. ሜታስታሲስ:- መንሽሮ ማህጸን ብሊምፋቲክ ሲስተም ወይ ብደም ኣቢሉ ናብ ካልእ ክፍሊ ኣካላት ክዝርጋሕ ይኽእል ኢዩ: እዚ ድማ ኣብ ርሑቕ ኣካላት ካልኣይ ደረጃ ዘለዎ መንሽሮ ከም ዝፍጠር ይገብር።

ናይ ማህጸን ካንሰር ፓቶፊዚዮሎጂ ምርዳእ ኣድማዒ ምክልኻል፣ ኣቐዲምካ ምልላይን ናይ ሕክምና ስትራተጂታትን ንምምዕባል ወሳኒ እዩ።

['መወከሲ']

PubMed/Medline https://www.nlm.nih.gov/databases/download/pubmed_medline.html

RefinedWeb https://arxiv.org/abs/2306.01116

Underwood SM: Breast cancer in African American women: nursing essentials. ABNF J. , 17 (1): 3-14.

Paliwal SR, Paliwal R, Agrawal GP, Vyas SP: Liposomal nanomedicine for breast cancer therapy. Nanomedicine (Lond). 2011, 6 (6): 1085-100.

Rauch GM, Adrada BE: Comparison of Breast MR Imaging with Molecular Breast Imaging in Breast Cancer Screening, Diagnosis, Staging, and Treatment Response Evaluation. Magn Reson Imaging Clin N Am. 2018, 26 (2): 273-280.

Wei H, Wang H, Ji Q, Sun J, Tao L, Zhou X: NRBP1 is downregulated in breast cancer and NRBP1 overexpression inhibits cancer cell proliferation through Wnt/β-catenin signaling pathway. Onco Targets Ther. 2015, 8 (): 3721-30.

Eden JA: Human breast cancer stem cells and sex hormones--a narrative review. Menopause. 2010, 17 (4): 801-10.

Schneider BP, Winer EP, Foulkes WD, Garber J, Perou CM, Richardson A, Sledge GW, Carey LA: Triple-negative breast cancer: risk factors to potential targets. Clin Cancer Res. 2008, 14 (24): 8010-8.

['ናይ ተሓታትነት መግለጺ: ሕክምናዊ']

['እዚ ወብ ሳይት ንትምህርትን ሓበሬታን ጥራይ እዩ ተዋሂቡ: ሕክምናዊ ምኽሪ ወይ ሞያዊ ኣገልግሎት ንምሃብ ተባሂሉ እተዳለወ ድማ ኣይኰነን።']

['እቲ ሓበሬታ ንዝኾነ ናይ ጥዕና ጸገም ወይ ሕማም ንምፍላጥ ወይ ንምሕካም ክውዕል የብሉን፣ እቶም ውልቃዊ ናይ ሕክምና ምኽሪ ዝደልዩ ድማ ምስ ፍቓድ ዘለዎ ሓኪም ክማኸሩ ኣለዎም።']

['እቲ መልሲ ናይቶም ሕቶታት ዝህብ ኔቭራል ኔት፡ ብፍላይ ኣብ ቁጽሪ ዝተሞርኮሰ ሓበሬታ፡ ንኣብነት፡ ብዝሒ ናይቶም ዝተለኽፉ ሰባት ምስ ዝኸውን፡ ኣዝዩ ዘይቅኑዕ ምዃኑ ኣስተብህል።']

['ኩሉ ግዜ ብዛዕባ ናይ ጥዕና ኩነታትካ ምኽሪ ናይ ሓኪምካ ወይ ካልእ ብቑዕ ናይ ጥዕና ኣገልጋሊ ድለ። ኣብዚ መርበብ ሓበሬታ ዘንበብካዮ ነገር ምኽንያት ናይ ሞያ ናይ ሕክምና ምኽሪ ዕሽሽ ኣይትበል። ናይ ሕክምና ህጹጽ ኩነታት ከጋጥመካ ይኽእል እዩ ኢልካ እንተሓሲብካ 911 ደውል ወይ ናብ ዝቐረበ ህጹጽ ክፍሊ ህጹጽ ረድኤት ብቅልጡፍ ኪድ። እዚ መርበብ ሓበሬታ ወይ ኣጠቓቕምኡ ናይ ሓኪምን ሕሙምን ርክብ ኣይፈጥርን። BioMedLib ወይ ሰራሕተኛታቱ ወይ ዝኾነ ኣበርካቲ ናይዚ መርበብ ሓበሬታ እዚ ኣብዚ ዝተዋህበ ሓበሬታ ወይ ኣጠቓቕምኡ ብዝምልከት ዝኾነ ይኹን መግለጺ ወይ ውክልና ኣይህብን እዩ።']

['ናይ መሰል ተሓታትነት']

['ናይ 1998 ዲጂታል ሚሊኒየም ሕጊ መሰል ደራሲ 17 U.S.C. § 512 (the DMCA) ኣብ ኢንተርኔት ዝረአ ዘሎ ትሕዝቶ ብመሰረት ሕጊ መሰል ደራሲ ኣሜሪካ መሰሎም ዝጥሕስ እዩ ኢሎም ንዝኣምኑ ወነንቲ መሰል ደራሲ ይምልከት። ']

['ዝኾነ ትሕዝቶ ወይ ማተርያል ምስ ዌብሳይትና ወይ ኣገልግሎትና ብምትሕሓዝ ዝተዳለወ ንናይ መሰል ዋንነትካ ዝጥሕስ እዩ ኢልካ ብጽቡቕ እምነት እንተኣሚንካ፣ ንስኻ (ወይ ወኪልካ) ነቲ ትሕዝቶ ወይ ማተርያል ክውገድ ወይ ድማ ናብኡ ምእታው ክኽልከል ዝሓትት ምልክታ ክትልእኸልና ትኽእል ኢኻ።']

['እቲ ምልክታ ብጽሑፍ ብኢሜይል ክለኣኽ ኣለዎ (ናይ ኢሜይል ኣድራሻ ንምርካብ ኣብ "Contact" ዝብል ክፋል ተመልከት) ።']

['እቲ DMCA እዚ ዝስዕብ ሓበሬታታት ክካተት ይሓትት፡ (1) መግለጺ ናይቲ ግህሰት ተፈጻምነት ኣለዎ ተባሂሉ ዝሕመ፡ (2) መግለጺ ናይቲ ግህሰት ተፈጻምነት ኣለዎ ተባሂሉ ዝሕመ ትሕዝቶን ነቲ ትሕዝቶ ክንረኽቦ ዘኽእለና እኹል ሓበሬታን (3) ናይ ርክብ ሓበሬታ፡ እንተላይ ኣድራሻኻ፡ ቁጽሪ ተሌፎንካን ናይ ኢመይል ኣድራሻኻን (4) እቲ ትሕዝቶ በቲ ጥርዓን ዝቐርበሉ መገዲ በቲ በዓል መሰል፡ ወይ ወኪሉ ወይ ብዝኾነ ሕጊ ከምዘይፍቀድ ጽቡቕ እምነት ከም ዘሎካ ዝገልጽ መግለጺ፡']

['(5) እቲ ኣብ ምልክታ ዘሎ ሓበሬታ ልክዕ ምዃኑን ነቲ ዝተጣሕሰ መሰል ናይ ምጥባቕ ስልጣን ከምዘለካን ብገበን ናይ ሓሶት ምስክርነት ዝተፈረመ መግለጺኻ፣']

["ከምኡ'ውን (6) ናይ ዋና መሰል ደራሲ ወይ ብስም ዋና መሰል ደራሲ ክሰርሕ ዝተፈቕደሉ ሰብ፡ ኣካላዊ ወይ ኤለክትሮኒካዊ ፊርማ። "]

['እዚ ኩሉ ኣብ ላዕሊ ዝተጠቕሰ ሓበሬታ ዘይምምላእ ነቲ ጥርዓንካ ናይ ምምላስ መስርሕ ክድንጉዮ ይኽእል እዩ።']

['ርክብ']

['ዝኾነ ሕቶ / ሓሳብ ምስ ዝህልወኩም ብኢሜይል ስደዱልና።']

What is pathophysiology of breast cancer?

Pathophysiology of breast cancer refers to the abnormal changes in the normal physiological processes and mechanisms that occur in the development and progression of breast cancer.

It involves the study of the underlying biological and molecular mechanisms that lead to the uncontrolled growth and spread of cancer cells in the breast tissue.

This includes the genetic, epigenetic, and environmental factors that contribute to the initiation, promotion, and progression of breast cancer.

Some of the key pathophysiological changes in breast cancer include:

1. Genetic mutations: Mutations in certain genes, such as BRCA1 and BRCA2, can increase the risk of developing breast cancer.

These mutations can be inherited or acquired during a person's lifetime.

2. Hormonal imbalances: Hormones, particularly estrogen, can play a role in the development and growth of breast cancer.

An imbalance in hormone levels or exposure to excess estrogen can increase the risk of breast cancer.

3. Inflammation: Chronic inflammation in the breast tissue can contribute to the development of breast cancer by promoting the growth and survival of cancer cells.

4. Tumor microenvironment: The environment surrounding the tumor, including the extracellular matrix, immune cells, and blood vessels, can influence the growth and spread of breast cancer.

5. Metastasis: Breast cancer can spread to other parts of the body through the lymphatic system or bloodstream, leading to the formation of secondary tumors in distant organs.

Understanding the pathophysiology of breast cancer is crucial for developing effective prevention, early detection, and treatment strategies.

Disclaimer: medical

This web site is provided for educational and informational purposes only and does not constitute providing medical advice or professional services.

The information provided should not be used for diagnosing or treating a health problem or disease, and those seeking personal medical advice should consult with a licensed physician.

Please note the neural net that generates answers to the questions, is specially inaccurate when it comes to numeric content. For example, the number of people diagnosed with a specific disease.

Always seek the advice of your doctor or other qualified health provider regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website. If you think you may have a medical emergency, call 911 or go to the nearest emergency room immediately. No physician-patient relationship is created by this web site or its use. Neither BioMedLib nor its employees, nor any contributor to this web site, makes any representations, express or implied, with respect to the information provided herein or to its use.

Disclaimer: copyright

The Digital Millennium Copyright Act of 1998, 17 U.S.C. § 512 (the “DMCA”) provides recourse for copyright owners who believe that material appearing on the Internet infringes their rights under U.S. copyright law. If you believe in good faith that any content or material made available in connection with our website or services infringes your copyright, you (or your agent) may send us a notice requesting that the content or material be removed, or access to it blocked. Notices must be sent in writing by email (see 'Contact' section for email address) . The DMCA requires that your notice of alleged copyright infringement include the following information: (1) description of the copyrighted work that is the subject of claimed infringement; (2) description of the alleged infringing content and information sufficient to permit us to locate the content; (3) contact information for you, including your address, telephone number and email address; (4) a statement by you that you have a good faith belief that the content in the manner complained of is not authorized by the copyright owner, or its agent, or by the operation of any law; (5) a statement by you, signed under penalty of perjury, that the information in the notification is accurate and that you have the authority to enforce the copyrights that are claimed to be infringed; and (6) a physical or electronic signature of the copyright owner or a person authorized to act on the copyright owner’s behalf. Failure to include all of the above information may result in the delay of the processing of your complaint.

['ብዛዕባ']

['BioMedLib ሕቶን መልስን ንምፍጣር ኣውቶማቲክ ኮምፒዩተራት (ማሽን-ሊንጊንግ ኣልጎሪዝም) ይጥቀም።']

["ካብ 35 ሚልዮን ናይ ባዮሜዲካል ጽሑፋት ናይ PubMed/Medline ጀሚርና፡ ከምኡ'ውን ናይ RefinedWeb ዌብሳይታት።"]

['ኣብ "References" ከምኡውን "Disclaimer" ተመልከት።']